A detailed history of Napatree Capital LLC transactions in Pfizer Inc stock. As of the latest transaction made, Napatree Capital LLC holds 25,561 shares of PFE stock, worth $730,277. This represents 0.58% of its overall portfolio holdings.

Number of Shares
25,561
Previous 25,561 -0.0%
Holding current value
$730,277
Previous $715 Million -0.0%
% of portfolio
0.58%
Previous 0.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $229,815 - $269,300
-9,098 Reduced 26.25%
25,561 $715 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $241,890 - $277,767
9,343 Added 36.91%
34,659 $888 Million
Q4 2023

Mar 26, 2024

BUY
$26.13 - $33.94 $661,507 - $859,225
25,316 New
25,316 $729 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Napatree Capital LLC Portfolio

Follow Napatree Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Napatree Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Napatree Capital LLC with notifications on news.